|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation of property and equipment | |||||
| Stock-based compensation | |||||
| Amortization of premiums and accretion of discounts on marketable securities | |||||
| Loss on sales of marketable securities | |||||
| Intangible asset amortization | |||||
| Right-of-use asset amortization | |||||
| Deferred income taxes | |||||
| Other non-cash adjustments, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Inventory | |||||
| Accounts payable and other liabilities | |||||
| Product revenue allowances | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Asset acquisition | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Sales and maturities of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Principal payments on finance leases | |||||
| Proceeds from exercise of stock options | |||||
| Tax obligations paid in connection with settlement of restricted stock units | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash | |||||
| Beginning of year | |||||
| End of year |
Loading...
